Leuvectin cancer gene therapy containing a gene for interleukin-2 to be injected directly into tumors: Began Phase I/II trial in 25 patients to evaluate safety

Vical Inc. (VICL), San Diego

Read the full 55 word article

How to gain access

Continue reading with a
two-week free trial.